NI
HCAT icon

Nepsis Inc’s Health Catalyst HCAT Stock Holding History

Nepsis Inc’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.92M Buy
2,976,187
+1,099,898
+59% +$1.59M 2.01% 21
2026
Q1 		$2.38M Sell
1,876,289
-39,505
-2% -$74.3K 0.8% 24
2025
Q4 		$4.58M Buy
1,915,794
+402,762
+27% +$1.1M 1.41% 23
2025
Q3 		$4.31M Sell
1,513,032
-212,033
-12% -$726K 1.37% 23
2025
Q2 		$6.5M Sell
1,725,065
-365,747
-17% -$1.44M 1.81% 23
2025
Q1 		$9.47M Buy
2,090,812
+1,994,555
+2,072% +$10.6M 2.34% 22
2024
Q4 		$10.1M Sell
96,257
-2,008,271
-95% -$16M 2.53% 21
2024
Q3 		$17.1M Buy
2,104,528
+851,448
+68% +$6.15M 4.06% 13
2024
Q2 		$8.01M Buy
1,253,080
+95,686
+8% +$614K 2.16% 20
2024
Q1 		$8.72M Buy
1,157,394
+65,462
+6% +$598K 2.36% 21
2023
Q4 		$10.1M Buy
1,091,932
+186,128
+21% +$1.52M 2.88% 20
2023
Q3 		$9.17M Buy
905,804
+63,065
+7% +$753K 2.81% 21
2023
Q2 		$10.5M Buy
842,739
+49,160
+6% +$585K 3.25% 19
2023
Q1 		$9.26M Sell
793,579
-188,702
-19% -$2.41M 3.08% 20
2022
Q4 		$10.4M Buy
982,281
+155,440
+19% +$1.5M 3.5% 15
2022
Q3 		$8.02M Buy
+826,841
New +$10.9M 2.9% 19
2022
Q1 		– Sell
-245,186
Closed -$9.71M – 33
2021
Q4 		$9.71M Buy
245,186
+30,032
+14% +$1.37M 2.82% 19
2021
Q3 		$10.8M Buy
215,154
+3,948
+2% +$215K 3.39% 17
2021
Q2 		$11.7M Sell
211,206
-11,425
-5% -$609K 3.71% 14
2021
Q1 		$10.4M Buy
222,631
+21,985
+11% +$1.06M 3.3% 17
2020
Q4 		$8.73M Buy
200,646
+3,468
+2% +$128K 3.18% 16
2020
Q3 		$7.22M Sell
197,178
-11,923
-6% -$405K 3.46% 14
2020
Q2 		$6.1M Sell
209,101
-5,340
-2% -$148K 2.95% 21
2020
Q1 		$5.61M Buy
214,441
+97,728
+84% +$2.99M 3.75% 16
2019
Q4 		$4.18M Buy
116,713
+8,011
+7% +$265K 2.12% 25
2019
Q3 		$3.1M Buy
+108,702
New +$4.28M 1.79% 27

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

Nepsis Inc's HCAT Position: Q2 2026 in Review

Nepsis Inc increased its Health Catalyst (HCAT) stake by 59% in Q2 2026, buying an estimated $1.59M and bringing the position to 2,976,187 shares worth $5.92M. The position accounts for 2.01% of the portfolio, ranked #21.

Nepsis Inc first reported a position in HCAT in Q3 2019 and has held it in 26 quarters since. The position peaked at $17.1M in Q3 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Nepsis Inc held 2,976,187 shares of Health Catalyst worth $5.92M as of Q2 2026.
  • Nepsis Inc bought 1,099,898 Health Catalyst shares in Q2 2026, an estimated $1.59M.
  • Health Catalyst made up 2.01% of Nepsis Inc's portfolio in Q2 2026, its #21 holding.
  • Nepsis Inc first reported a position in Health Catalyst in Q3 2019 and has held it in 26 quarters since.
  • Nepsis Inc's Health Catalyst position peaked at $17.1M in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Nepsis Inc's 13F filing for Q2 2026, filed 14 Jul 2026.